Congress Presentations

Stay informed about the latest scientific and medical research from Axsome.

Filter

Sort

American Society of Clinical Psychopharmacology Annual Meeting

Miami, FL | May 26 - 29, 2026

AXS-05 | Major Depressive Disorder

Anxiolytic Effects of Dextromethorphan-Bupropion (45mg/105mg): Post Hoc Analyses Across Trials in Major Depressive Disorder

View / Download

AXS-05 | Major Depressive Disorder

Effects of Dextromethorphan-Bupropion (45mg/105mg) in Participants with Major Depressive Disorder and Anxious Distress

View / Download

AXS-05 | Major Depressive Disorder

Real-World Clinical Outcomes of Patients Switching to Treatment With Dextromethorphan-Bupropion (45 mg/105 mg)

View / Download

Solriamfetol | Excessive Daytime Sleepiness

Effects of Solriamfetol on Neuropsychological Outcomes in Patients With Obstructive Sleep Apnea in the Real-World SURWEY Study

View / Download

This site contains scientific information about investigational compounds and/or information about products and/or uses that have not been approved by the US Food and Drug Administration. The safety and efficacy of investigational products and/or investigational uses of approved products has not been established and such investigational products/uses have not and may not be approved for marketing by any health authority.

AXSOME, AUVELITY, SUNOSI, SYMBRAVO and their logos are trademarks or registered trademarks of Axsome Therapeutics, Inc. or its affiliates. Other trademarks are property of their respective owners.